Filing Details

Accession Number:
0001209191-22-010403
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-16 20:10:43
Reporting Period:
2022-02-09
Accepted Time:
2022-02-16 20:10:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124105 Catalyst Biosciences Inc. CBIO Pharmaceutical Preparations (2834) 562020050
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769866 E. Seline Miller C/O Catalyst Biosciences, Inc.
611 Gateway Boulevard, Suite 710
South San Francisco CA 94080
Svp Finance; Interim Cfo & Pao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-09 3,250 $0.46 3,250 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
Footnotes
  1. Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2022.